Assignee
AMBIT BIOSCIENCES CORP
US·28 granted patents·17 pending applications·116 citations·filing 2002–2017
Top patents by PatentIndex Score
45 records- 0195US8357690B2Methods of treatment using combination therapyAMBIT BIOSCIENCES CORP·Filed 2010·Granted Jan 22, 2013·25 cites·44 claims
- 0290US7820657B2Imidazolothiazole compounds for the treatment of diseaseAMBIT BIOSCIENCES CORP·Filed 2007·Granted Oct 26, 2010·13 cites·37 claims
- 0389US9320739B2RAF kinase modulator compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2015·Granted Apr 26, 2016·6 cites·11 claims
- 0488US8969587B2RAF kinase modulator compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2013·Granted Mar 3, 2015·8 cites·14 claims
- 0586US8349851B2JAK kinase modulating compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2010·Granted Jan 8, 2013·9 cites·19 claims
- 0685US8836218B2Methods of treatment using combination therapyAMBIT BIOSCIENCES CORP·Filed 2013·Granted Sep 16, 2014·3 cites·27 claims
- 0783US7750160B2Isoxazolyl urea derivatives as kinase modulatorsAMBIT BIOSCIENCES CORP·Filed 2004·Granted Jul 6, 2010·17 cites·31 claims
- 0878US10053430B2RAF kinase modulator compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2017·Granted Aug 21, 2018·1 cites·2 claims
- 0977US9725465B2Biaryl acetamide compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2014·Granted Aug 8, 2017·3 cites·4 claims
- 1075US9730937B2RAF kinase modulator compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2016·Granted Aug 15, 2017·1 cites·19 claims
- 1175US8927711B2JAK kinase modulating compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2012·Granted Jan 6, 2015·2 cites·19 claims
- 1275US8921546B2Imidazolothiazole compounds for the treatment of diseaseAMBIT BIOSCIENCES CORP·Filed 2013·Granted Dec 30, 2014·1 cites·1 claims
- 1373US7968543B2Methods of administering N-(5-tert-butyl-isoxazol-3-yl)-N′-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea to treat proliferative diseaseAMBIT BIOSCIENCES CORP·Filed 2008·Granted Jun 28, 2011·8 cites·45 claims
- 1473US7833741B2Uncoupling of DNA insert propagation and expression of protein for phage displayAMBIT BIOSCIENCES CORP·Filed 2006·Granted Nov 16, 2010·2 cites·13 claims
- 1572US9452167B2Heterocyclic compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2014·Granted Sep 27, 2016·1 cites·20 claims
- 1672US7897381B2Uncoupling of DNA insert propagation and expression of protein for phage displayAMBIT BIOSCIENCES CORP·Filed 2007·Granted Mar 1, 2011·1 cites·11 claims
- 1771US9585892B2Solid forms comprising N-(5-tert-butyl-isoxazol-3-yl)-N′-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewithAMBIT BIOSCIENCES CORP·Filed 2014·Granted Mar 7, 2017·1 cites·20 claims
- 1870US7767670B2Substituted 3-carboxamido isoxazoles as kinase modulatorsAMBIT BIOSCIENCES CORP·Filed 2004·Granted Aug 3, 2010·4 cites·24 claims
- 1969US7323490B2Pyrrole compounds and uses thereofAMBIT BIOSCIENCES CORP·Filed 2004·Granted Jan 29, 2008·5 cites·16 claims
- 2069US7112435B1Uncoupling of DNA insert propagation and expression of protein for phage displayAMBIT BIOSCIENCES CORP·Filed 2002·Granted Sep 26, 2006·4 cites·11 claims
- 2166US9555040B2Methods of treating proliferative diseasesAMBIT BIOSCIENCES CORP·Filed 2014·Granted Jan 31, 2017·1 cites·23 claims
- 2266US9295672B2Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2014·Granted Mar 29, 2016·0 cites·23 claims
- 2366US8952020B2Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2014·Granted Feb 10, 2015·0 cites·24 claims
- 2464US2015126505A1Imidazolothiazole compounds for the treatment of diseaseAMBIT BIOSCIENCES CORP·Filed 2014·Application pending·0 cites
- 2562US2005009099A1Assays and kits for detecting protein bindingAMBIT BIOSCIENCES CORP·Filed 2004·Application pending·0 cites
- 2661US2005153989A1Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseasesAMBIT BIOSCIENCES CORP·Filed 2005·Application pending·0 cites
- 2761US2017348320A1Imidazolothiazole compounds for the treatment of diseaseAMBIT BIOSCIENCES CORP·Filed 2017·Application pending·0 cites
- 2861US2005165029A1Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseasesAMBIT BIOSCIENCES CORP·Filed 2005·Application pending·0 cites
- 2959US9308207B2JAK kinase modulating compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2014·Granted Apr 12, 2016·0 cites·19 claims
- 3059US2008176248A1Phage display affinity and specificity filters and forward screenAMBIT BIOSCIENCES CORP·Filed 2007·Application pending·0 cites
- 3156US2005239806A1Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseasesAMBIT BIOSCIENCES CORP·Filed 2005·Application pending·0 cites
- 3255US8952058B2Heterocyclic compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2012·Granted Feb 10, 2015·0 cites·13 claims
- 3353US2005187389A1Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseasesAMBIT BIOSCIENCES CORP·Filed 2005·Application pending·0 cites
- 3453US2015353528A1Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2015·Application pending·0 cites
- 3553US2004248957A1Heterocyclic compounds and uses thereofAMBIT BIOSCIENCES CORP·Filed 2004·Application pending·0 cites
- 3653US2004242673A1Heterocyclic compounds and uses thereofAMBIT BIOSCIENCES CORP·Filed 2004·Application pending·0 cites
- 3752US9938261B2Heterocyclic compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2016·Granted Apr 10, 2018·0 cites·23 claims
- 3852US2004248972A1Compounds and uses thereofAMBIT BIOSCIENCES CORP·Filed 2004·Application pending·0 cites
- 3951US2011269740A1Jak kinase modulating compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2009·Application pending·0 cites
- 4051US2005182125A1Pyrrole compounds and uses thereofAMBIT BIOSCIENCES CORP·Filed 2004·Application pending·0 cites
- 4150US9611253B2Solid forms comprising optically active pyrazolylaminoquinazoline, compositions thereof, and uses therewithAMBIT BIOSCIENCES CORP·Filed 2013·Granted Apr 4, 2017·0 cites·18 claims
- 4247US2005153371A1Conjugated small moleculesAMBIT BIOSCIENCES CORP·Filed 2005·Application pending·0 cites
- 4345US2010173917A1Urea derivatives as abl modulatorsAMBIT BIOSCIENCES CORP·Filed 2010·Application pending·0 cites
- 4442US9675549B2Tablet containing composite with cyclodextrinAMBIT BIOSCIENCES CORP·Filed 2013·Granted Jun 13, 2017·0 cites·9 claims
- 4537US2013035326A1Biaryl compounds and methods of use thereofAMBIT BIOSCIENCES CORP·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when AMBIT BIOSCIENCES CORP files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →